Metraipolis › archive › dc_b7205219749f

Multimodal MRI Assessment of neuroprotective effects of Ofatumumab on brain structure, function, and clinical correlates in Relapsing Multiple Sclerosis — Europe PMC PMID:41798819

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41798819
DOI
10.3389/fneur.2026.1738469
License (as archived)
solo-consultazione
Archived
2026-11-05T14:53:55.021Z
SHA-256 of the archived text
aab680d9268e7d02f244172e67bf58847b59725c40e85b2c54c640c6aa02ffdb
Stable URL of this page
https://metraipolis.com/documento/dc_b7205219749f

How to cite

Multimodal MRI Assessment of neuroprotective effects of Ofatumumab on brain structure, function, and clinical correlates in Relapsing Multiple Sclerosis — Europe PMC PMID:41798819 — Europe PMC (en), https://europepmc.org/article/MED/41798819 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b7205219749f (Metraipolis archive dc_b7205219749f, sha256 aab680d9268e7d02f244172e67bf58847b59725c40e85b2c54c640c6aa02ffdb)
BibTeX
@misc{dcb7205219749f,
  title = {Multimodal MRI Assessment of neuroprotective effects of Ofatumumab on brain structure, function, and clinical correlates in Relapsing Multiple Sclerosis — Europe PMC PMID:41798819},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41798819},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b7205219749f; sha256 aab680d9268e7d02f244172e67bf58847b59725c40e85b2c54c640c6aa02ffdb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41798819. Agents can read the archived copy with the MCP tool read_document.